Juxtapid

Primary Use

Juxtapid is specifically indicated for people with homozygous familial hypercholesterolemia (HoFH). This is a rare, inherited condition that causes extremely high levels of low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol, from a very young age.

How It Is Used

This medication is not intended to be used alone. It is prescribed as part of a comprehensive treatment plan that typically includes:

• A consistent low-fat diet (where less than 20% of calories come from fat).
• Other cholesterol-lowering medications.
• Other lipid-lowering treatments, such as LDL apheresis (a procedure that filters cholesterol out of the blood).

Treatment Goals

The goal of treatment with Juxtapid is to reduce the levels of several types of fats and proteins in the blood, including:

• Low-density lipoprotein cholesterol (LDL-C).
• Total cholesterol.
• Apolipoprotein B (a protein found in LDL cholesterol).
• Non-high-density lipoprotein cholesterol (non-HDL-C).

It has not been established whether Juxtapid reduces the risk of heart disease or stroke. It is also not recommended for individuals with high cholesterol who do not have the specific genetic diagnosis of HoFH.

Mechanism of Action

Juxtapid belongs to a class of medications known as microsomal triglyceride transfer protein (MTP) inhibitors. It is used to lower cholesterol in patients with a rare genetic condition called homozygous familial hypercholesterolemia (HoFH).

How It Lowers Cholesterol

The medication works by targeting the process the body uses to package and transport fats. Its primary actions include:

• Inhibiting MTP: Juxtapid binds to and blocks MTP, a protein found in the liver and the intestines.
• Preventing Assembly: MTP is necessary for the assembly of fat-carrying particles known as very-low-density lipoproteins (VLDL) and chylomicrons. When MTP is inhibited, these particles cannot be properly formed.
• Reducing Release: Because these particles cannot be assembled, the liver and intestines release fewer of them into the blood.

Since VLDL is a precursor to low-density lipoprotein (LDL), which is often referred to as "bad" cholesterol, reducing the production of VLDL leads to a significant decrease in the amount of LDL cholesterol circulating in the body. This mechanism allows the drug to lower cholesterol levels through a different pathway than other common cholesterol medications, such as statins.

Common Side Effects

The most frequent side effects associated with Juxtapid involve the digestive system. These symptoms often occur because of how the medication affects fat absorption and may include:

• Diarrhea
• Nausea and vomiting
• Stomach pain or cramping
• Indigestion
• Gas and bloating
• Constipation
• Weight loss

Digestive side effects are often more severe if the medication is taken with a high-fat meal. Following a low-fat diet as directed by a healthcare provider may help reduce these symptoms.

Serious Side Effects

While less common, some side effects can be severe and require immediate medical attention. These include:

• Liver problems: Juxtapid can cause changes in liver enzyme levels or liver damage. Symptoms may include yellowing of the skin or eyes (jaundice), dark-colored urine, light-colored stools, or unusual fatigue.
• Severe abdominal pain: Intense pain in the upper stomach area.
• Chest pain: Any new or worsening chest discomfort should be reported to a healthcare provider.

Liver Toxicity

Juxtapid can cause elevations in liver enzymes and an increase in liver fat, known as hepatic steatosis. These changes may lead to more severe liver disease, such as cirrhosis, over time. Because of this risk, the medication is only available through the Juxtapid REMS restricted distribution program. Healthcare providers must perform blood tests to monitor liver function before starting the medication and at regular intervals during treatment.

Pregnancy and Fetal Risk

This medication is contraindicated in individuals who are pregnant. Based on animal studies, Juxtapid may cause significant harm to a developing fetus. Patients who can become pregnant must have a negative pregnancy test before starting treatment and must use effective contraception while taking the drug.

Drug Interactions

Juxtapid has significant interactions with many other substances. It must not be used with moderate or strong CYP3A4 inhibitors, such as certain antibiotics, antifungals, and protease inhibitors, as these can dangerously increase the levels of Juxtapid in the blood. It may also interact with grapefruit juice, warfarin, and certain cholesterol-lowering statin medications.

Gastrointestinal Effects

Gastrointestinal side effects are very common and can be severe. These include diarrhea, nausea, vomiting, and abdominal pain. To help manage these symptoms, patients are typically advised to follow a diet where less than 20 percent of daily calories come from fat.

Nutritional Deficiencies

Because Juxtapid interferes with the absorption of dietary fat, it can also reduce the absorption of fat-soluble vitamins (A, D, E, and K) and essential fatty acids. Patients are generally required to take daily nutritional supplements to prevent deficiencies.

Other Contraindications

Juxtapid should not be used by individuals with moderate or severe liver impairment or those with active liver disease.

Pregnancy

Juxtapid is contraindicated for use during pregnancy because it may cause fetal harm. Before starting this medication, healthcare providers typically require a negative pregnancy test for individuals of childbearing potential.

Effective contraception must be used during treatment with Juxtapid. If you become pregnant or suspect you are pregnant while taking this medication, it is important to contact a healthcare professional immediately to discuss the potential risks to the fetus and determine the next steps for your treatment.

Breastfeeding

It is not known if Juxtapid passes into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, breastfeeding is generally not recommended while taking this medication. Patients should consult with their healthcare provider to weigh the benefits of breastfeeding against the potential risks of the medication or to discuss alternative treatment options.

Dosage Forms

Juxtapid is supplied as a capsule for oral administration. It is available in various strengths to allow for dose titration as directed by a healthcare professional.

• Oral capsule

FDA Approval and Indication

Juxtapid (lomitapide) received FDA approval in December 2012. It is specifically indicated for use alongside a low-fat diet and other lipid-lowering therapies to reduce cholesterol levels in adults diagnosed with homozygous familial hypercholesterolemia (HoFH).

Boxed Warning and Liver Safety

The FDA has issued a boxed warning for Juxtapid because it can cause serious liver-related issues, including elevations in liver enzymes and the accumulation of fat in the liver (hepatic steatosis). These conditions may lead to more severe liver damage if not monitored closely. Healthcare professionals are required to perform liver tests before starting the medication and at regular intervals during therapy.

REMS Program

Due to the risk of hepatotoxicity, Juxtapid is available only through a restricted program called the Juxtapid REMS (Risk Evaluation and Mitigation Strategy). The goals of this program are to educate healthcare providers and patients about the risk of liver toxicity and the need for regular monitoring. Only certified prescribers and pharmacies are permitted to distribute the drug.

Regulatory Oversight

The FDA continues to monitor the safety profile of Juxtapid through systems like the FDA Adverse Event Reporting System (FAERS). Regulatory actions and safety communications are issued as needed to ensure the benefits of the medication outweigh its risks for the approved patient population.

Cost and Insurance Coverage

Juxtapid is classified as a specialty medication, which means it is generally more expensive than standard prescription drugs. The total out-of-pocket cost for the medication depends on your specific insurance plan, your pharmacy, and whether you are eligible for financial assistance.

Generic Availability

There is currently no generic version of Juxtapid (lomitapide) available in the United States. It is only available as a brand-name product, which often results in higher costs than medications with generic alternatives.

Insurance and Prior Authorization

Most health insurance providers require prior authorization before they will cover Juxtapid. This process requires your healthcare provider to submit medical documentation to the insurance company to prove the medication is necessary for your specific condition. Even with insurance coverage, you may still be responsible for significant copayments or coinsurance.

Restricted Distribution

Juxtapid is not sold at most retail pharmacies. It is distributed through a restricted program called the Juxtapid REMS (Risk Evaluation and Mitigation Strategy). Because of the risk of liver toxicity, the medication must be dispensed by certified specialty pharmacies that are equipped to manage the requirements of the REMS program.

Financial Assistance

Because of the high cost of treatment, financial support may be available for eligible patients. These options often include:

• Manufacturer co-pay cards for patients with commercial insurance.
• Patient assistance programs for individuals who are uninsured or meet specific income requirements.

Patients are encouraged to speak with their healthcare provider or a specialty pharmacist to identify available support programs.